Hot Low Price Stocks To Invest In Right Now

In my very first MannKind article I offered for my SA readers, I made the following statement:

Wall Street gurus are always smarter than the retail investor that doesn’t do their homework.

I have mentioned several times that MannKind’s (NASDAQ:MNKD) management understands the reality and has done a remarkable job in keeping the company hooked up to a life support system that has allowed them to be one of the few (other than the short-sellers) to benefit from these four years of futility for the retail investors. In recent days, with the flurry of superfluous SEC filings and press releases this has only resulted in the stock falling to a near all-time low price. The time is neigh for this saga becoming history so we can close the books on this financial fiasco. It’s now clear who has done their homework on MannKind!

Hot Low Price Stocks To Invest In Right Now: Fogo de Chao, Inc.(FOGO)

Advisors’ Opinion:

  • [By Monica Gerson]

    Fogo De Chao Inc (NASDAQ: FOGO) is expected to post its quarterly earnings at $0.28 per share on revenue of $76.80 million.

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

Hot Low Price Stocks To Invest In Right Now: Peak Resorts, Inc.(SKIS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Peak Resorts Inc (NASDAQ: SKIS) is projected to report its quarterly earnings at $0.40 per share on revenue of $42.59 million.

    BMC Stock Holdings Inc (NASDAQ: STCK) is expected to post its quarterly earnings at $0.17 per share on revenue of $449.59 million.

Hot Low Price Stocks To Invest In Right Now: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Bryan Murphy]

    As much progress as the remote medical monitoring device market has made in recent years, we’ve still only scratched the surface. The surface has been scratched though. The Dexcom G5 mobile glucose monitor from DexCom, Inc. (NASDAQ:DXCM) is one impressive example. Arguably the first and best entry in the race, DexCom has sent a clear message that consumers and caregivers are ready for a functional device that takes care of itself.

    At the other end of the spectrum is a recent round of products that are less clinical in nature, and more broad-usage friendly. Devices like the Apple Inc. (NASDAQ:AAPL) watch and the Fitbit Inc (NYSE:FIT) line of products are both capable of monitoring heart rates and activity. On the other, neither does it all that well… not like one would expect in a clinical setting. Fitbit has run into a headwind of legal and reputational trouble since it’s been verified that its trackers aren’t all that accurate; Apple avoided such trouble largely because few consumers ever viewed its watches as medical-grade hardware.

    The gap between the Dexcom G5 and the Fitbit fitness trackers, however, is where real opportunity lies. See, the entries to date have proven there is a market for mobile medical devices , but have also proven they have to work as well as the equipment one might expect to find in a doctor’s office or in a hospital.

    It’s this subtle nuance that puts a young company called Biotricity Inc. (OTCMKTS:BTCY) in the spotlight, as it has melded mobile monitoring and quality monitoring, and is now in the midst of making sure they’re marketable… not just to consumers, but to insurance companies (which tend to pay a lot more than the average consumer does). Fitbit missed the mark on both fronts.

    Biotricity is working two different but similar pieces of technology. One is called bioflux, for use by caregivers in a clinical setting, and the other is biolife individuals outside of a clinical setting. Neither is o

  • [By Tracey Ryniec]

    Fitbit is the latest tech gadget sensation. It has 22% of the wearables market and it looks like this holiday season could be huge for the company. Fitness and wellness are a big market globally which Fitbit is only beginning to tap. 

  • [By Matthew Cochrane]

    In January 2016, Mastercard reached an agreement with the wearable payment platform Coin, in a collaboration to introduce more payment features in wearables. Since the collaboration, Coin was acquired by Fitbit Inc(NYSE:FIT), meaning Mastercard might have an early edge among payments companies to break into the wearable market in a big way.

Hot Low Price Stocks To Invest In Right Now: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

Hot Low Price Stocks To Invest In Right Now: Vince Holding Corp.(VNCE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 15 percent to $3.67. Vince Holding projects full-year sales and EPS to come in at or below the low end of its earlier issued outlook.

  • [By Peter Graham]

    Small cap upscale apparel brandretailer Vince Holding Corp (NYSE: VNCE) reported Q1 2017 financial results before the market opened this morning. Net sales decreased 14.2% to $58.0 million as wholesale segment sales decreased 20.9% to $35.4 million, primarily due to a reduction in full-price orders as a result of the elimination of the Companys summer delivery, and asdirect-to-consumer segment salesfell 1.0% to $22.6 million. Comparable sales decreased 5.7%, including e-commerce sales, due to a decrease in average order value.

  • [By Lisa Levin]

    Shares of Vince Holding Corp (NYSE: VNCE) were down around 41 percent to $0.800. Vince Holding reported a Q4 loss of $162.1 million on revenue of $63.9 million.

Hot Low Price Stocks To Invest In Right Now: Lucas Energy, Inc.(LEI)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    The Interior Department is in charge of managing regulations around oil and gas drilling around the nation. Currently, the favorite appears to be Forrest Lucas, the 74-year-old founder of Lucas Energy Inc. (NYSEMKT: LEI). A career energy executive, Lucas recently told Investors Business Daily that he would be interested in the job because “it’s a very important position and you need to have someone in there who knows what they’re doing.” However, Lucas has never actually met Trump in person.

Hot Biotech Stocks To Watch Right Now

bluebird bio, (NASDAQ:BLUE) is one of the oncology immunotherapy stocks I mentioned recently as worth a good look, (article titled ‘Immunotherapy Over Reaction’, a basic primer to the immunotherapy subsector and its ETF). BLUE is also a recent Cramer pick. Immunotherapy stocks have been hit hard over the summer but BLUE is a relatively highly valued genetic specialist, with some interesting early results.

Early-stage biotech stocks are generally more likely to be recognized for their high risk than any material value, (Biotech notoriously hard to value). However, depending on available funding from their partners, pipeline maturity compared to burn rate, and management experience, it could well be that there’s an overlooked opportunity here, also since BLUE has recently announced a funding initiative, the dilution expectation could create an opportunity for interested future “bluebirds”.

Hot Biotech Stocks To Watch Right Now: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Paul Ausick]

    ArQule Inc. (NASDAQ: ARQL) dropped about 23% Friday, to post a new 52-week low of $1.13 after closing at $1.47 on Thursday. The stock’s 52-week high is $2.17. Volume was about 15 times the daily average of around 150,000 shares. The biopharmaceutical company said this morning that a phase 3 trial of a cancer drug did not meet the primary endpoint of improving overall survival.

Hot Biotech Stocks To Watch Right Now: Amgen Inc.(AMGN)

Advisors’ Opinion:

  • [By Johanna Bennett]

    Shares of Amgen (AMGN) led the drop in the S&P 500 today falling almost 6.4% to close at $168.61 after the drug maker unveiledlong-awaited data on its anti-cholesterol drug Repatha.

    Can shares of Amgen rebound from todays selloff?

    Yes, is the answer from RBC Capital Management analyst Michael Yee. He argues that the drug makers share price can grind back up if access to Repatha increases over the next few quarters. Earlier today, Amgen released data from an outcome study that missed expectations, leading some analyst to predict that health plans will continue to restrict access to the drug.

    As Yee writes:

    A number of key developments midday at the ACC conference that should shed increased confidence that Repatha reimbursement and utilization will continue to increase over time driving a new growth driver for AMGN and increased confidence in a new product cycle. If reimbursement does start to open up over next few quarters (tracking IMS scripts and other datapoints) and AMGN manages their execution on quarters/guidance – stock should recover off today’s overreaction reflecting high expectations

  • [By Chris Lange]

    Amgen Inc. (NASDAQ: AMGN) saw its short interest increase to 7.78 million shares from the previous level of 7.38 million. Shares closed most recently at $145.34, in a 52-week trading range of $133.64 to $176.85.

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), and Amgen (NASDAQ:AMGN) stand out as three of the most likely suitors for Incyte. Here’s why these big drugmakers could be interested in making a significant acquisition.

  • [By Ben Levisohn]

    Three biotech stocks–Alexion Pharmaceuticals (ALXN), Amgen (AMGN), and Celgene (CELG)–reported earnings since yesterday’s close. But just one has seen its shares head higher after the announcement.

Hot Biotech Stocks To Watch Right Now: Biogen Idec Inc(BIIB)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Biogen (BIIB)

    Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was Biogen Inc. (NASDAQ: BIIB) which traded down 4.6% at $279.08. The stocks 52-week range is $223.02 to $333.65. Volume was 3.4 million versus the daily average of 1.6 million shares.

  • [By Brian Orelli]

    While that’s fine for clinical trials, it may make it difficult for Ionis’ drugs to compete with drugs that work as well but don’t have side effects that need to be monitored. Of course, for Spinraza, which Biogen (NASDAQ:BIIB) and Ionis recently got approved for spinal muscular atrophy, side effects aren’t an issue because there aren’t any other treatment options at the moment.

  • [By Ben Levisohn]

    Biogen (BIIB) has dropped 2.2% to $286.16 after getting cut to Market Perform from Outperform at Leerink, and to Equal Weight from Overweight at Morgan Stanley.

  • [By Ben Levisohn]

    Biogen (BIIB) tumbled to the bottom of the S&P 500 today after getting cut by two analysts.

    Agence France-Presse/Getty Images

    Biogen dropped 4.7% to $278.96 at 4:19 p.m. today, while the S&P 500 declined 0.2% to 2,381.38.

    Leerinks Geoffrey Porges cited the “slower than expected ramp for Spinraza” in cutting Biogen to Market Perform from Outperform, while Morgan Stanly’s Matthew Harrison wrote that his decision to cut Biogen to Market Weight from Overweight was “not a downside call, but a timing call.”

    Biogen’s market capitalization fell to $60.2 billion today from $63.2 billion yesterday. It reported net income of $3.7 billion on sales of $10.2 billion in 2016.

    Barron’s Teresa Rivas recommended buying Biogen in December after the company released positive trial data on its Alzheimer’s drug.

  • [By Todd Campbell]

    A new and highly anticipated study byCelgene Corp. (NASDAQ:CELG) shows that its promising multiple sclerosis drug could soon reshape the $19 billion multiple sclerosis market. On Friday, management reported that ozanimod met its primary endpoint for reducing MS relapses better than Biogen Inc.’s (NASDAQ:BIIB) Avonex, and importantly, it did so without any new safety risks.

Hot Biotech Stocks To Watch Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

Hot Biotech Stocks To Watch Right Now: Medivation Inc.(MDVN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    RBC’s Simos Simeonidis and Matthew Eckler try to find the right comparison for Pfizer’s (PFE) purchase of Medivation (MDVN):

    Scott Eisen/Bloomberg News

    We were obviously wrong with our Sector Perform rating: while we knew an M&A transaction was definitely a good possibility, we just could not get to this level of valuation using a realistic Xtandi model and thus could not recommend the stock. The only way for us to get to $81.50 (or even to $60-$70/share) would have been to assign very significant value to talazoparib. And we could not do that given the amount of available clinical evidence.Medivation shareholders who held on to their shares past the $50′s, did just that, were proven right and are now rewarded for it, since they believed that someone would be willing to pay for this asset just months ahead of Phase III data. The key question is why would a company be willing to part with what they claim/think may be a multibillion dollar drug that works in multiple cancers. We believe the obvious answer is because they’re smart and understand drug development risk better than most. We’ll know in a matter of months whether Pfizer/Medivation is like Amgen (AMGN)-Onyx (carfilzomib) or not.

  • [By Ben Levisohn]

    Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:

  • [By Ben Levisohn]

    Well, it looks like Medivation (MDVN) now has five suitors after reports that Amgen (AMGN) is joining Pfizer (PFE), Sanofi (SNY), AstraZeneca (AZN) and Novartis (NVS) in considering a bid. Maxim’s Jason Kolbert and Jason McCarthy offer their thoughts:

    Medivation reports tonight at 4:30pm…

    We expect the focus to be on the recent proposals from Sanofi (SNY $38.75- NR); Pfizer (PFE $33.40 -NR), AstraZeneca (AZN $28.26-NR) and just today, Amgen (AMGN – $154.18 – NR)…

    Medivation is returning to new highs as suitors line up to make acquisition bids. In this scenario what is the right discount rate for modeling purposes?

    We believe our model for Xtandi revenues is good, therefore we review our risk rating and determine the following: 30% = $47 15% = $76 10% = $99

    With Medivation’s board having now said No to anything less than $65 per share, it suggests to us that the stability and predictability of Xtandi’s revenues is greater than we thought, the risk is lower. Our intermediate risk rating is 15% or $76 fair value.

    Shares of Medivation rose 0.3% to $59.22 today, while Pfizer gained 0.5% to $33.56, Sanofi fell 0.5% to $39.07, AstraZeneca dropped 0.6% to $39.07, Novartis declined 0.3% to $74.12, and Amgen ticked up 0.1% to $154.25.

     

  • [By Monica Gerson]

    Medivation Inc (NASDAQ: MDVN) is said to have spurned recent takeover approach from France’s Sanofi SA (ADR) (NYSE: SNY), according to sources as reported by Bloomberg on Tuesday. Sanofi wants Medivation’s treatments for hard-to-cure cancers, the sources said. Medivation shares surged 8.46 percent to $49.60 in the after-hours trading session, while Sanofi shares fell 0.59 percent to $42.02 in after-hours trading.

Hot Biotech Stocks To Watch Right Now: ARIAD Pharmaceuticals Inc.(ARIA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.73 percent in trading on Monday. Meanwhile, top gainers in the sector included Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA), and VCA Inc (NASDAQ: WOOF).

USD/JPY Forecast: 111.74 or 113.20?

On Monday, the Dollar-Yen pair witnessed a solid rally from the low of 111.89 to 112.72 as the US 10-year treasury yield rose from 2.32 percent to 2.372 percent. Despite the strong bid tone, the currency pair failed to cut through the upward sloping 50-day MA and ended the day at 112.61 levels.

Little action was seen in the Asian session as the treasury yield remained flat lined. Currently, it is trading at 112.55 levels; having clocked a high of 112.70. The data docket is thin, also the moves could be contained, given the North American traders are away from their desks. Still, the spot could witness big moves if Yellen speech offers hawkish/dovish surprise during her speech scheduled at 23:00 GMT.

As for the technical charts, the spot looks set to revisit 113.00 levels in the next 24 hours.

1-hour chart

The above chart shows a potential inverse head and shoulders pattern with neckline hurdle at 112.73. Interestingly, the inverse head and shoulders pattern has been formed at the 111.90 – 38.2% Fib. of Sep. 8 low – Jun. 6 high.
The 50-MA (currently at 112.34) has shed bearish bias and is likely to act as a strong support. Also, the descending trendline has been challenged since last 11 hours and is likely to fall soon.
Daily chart

The daily chart clearly favors the bears, given the nice topping pattern and a break below 113.00 levels last week.
The RSI is below 50.00 (in bearish territory). Also, today's move above the 5-day MA has been short-lived. Thus, the spot looks set to revisit 111.90 levels.
The only factor that favors the bulls is the upward sloping 50-day MA (currently at 112.76).
View

Bearish scenario: Drop to 111.74 (200-day MA) – A break below 112.34 (1-hour 50-MA) would add credence to the failure to hold above the 5-day MA and shall open doors for a drop to 111.74 (200-day MA).

Bullish scenario: A break above 112.73 (inverse head and shoulders neckline) could yield a rally to 113.20 levels.

Top 5 Insurance Stocks To Invest In 2018

Annuities and Trusts: A Tricky Combination

6 Ways the Senate Tax Bill Could Juice the Life Sector

7 Proven Ways to Kill Your Next Sale

The tax policy specialists who work with the life insurance and annuity community are still studying the 253-page description of the Senate’s version of the Tax Cuts and Jobs Act bill.

One point is already clear: The Senate bill drafters hope life and annuity players will contribute about $25 billion extra over 10 years, or an average of $2.5 billion extra per year, with most of the cash coming out what life and annuity issuers pay to bring in customers.

U.S. life and annuity issuers collect about $500 billion in payments per year, according to data from the National Association of Insurance Commissioners.

(Related: Two Big New House Tax Bill Changes Could Affect You)

Tax bill drafters at the Senate Finance Committee produced a life insurance provisions section that’s different from the version in the current House tax bill — H.R. 1. Members of the House Ways and Means Committee approved the House version of H.R. 1 along a 24-16, party-line vote Thursday.

Top 5 Insurance Stocks To Invest In 2018: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

Top 5 Insurance Stocks To Invest In 2018: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 5 Insurance Stocks To Invest In 2018: Aon Corporation(AON)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    We’re seeing the exact same price pattern playing out in shares of $29 billion risk and insurance consultancy firm Aon plc (AON) . Aon has been a strong performer for all of 2016, up 20% since the calendar flipped to January. But don’t worry if you’ve missed the move – an ascending triangle pattern is signaling a second leg higher here. For Aon, the breakout level to watch is resistance up at $113.

Top 5 Insurance Stocks To Invest In 2018: American International Group Inc.(AIG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Dr Pepper Snapple Group Inc. (NYSE: DPS) to report quarterly earnings at $1.06 per share on revenue of $1.57 billion before the opening bell. Dr Pepper Snapple shares fell 0.07 percent to close at $93.49 on Monday.
    Analysts expect American International Group Inc (NYSE: AIG) to post quarterly earnings at $1.01 per share on revenue of $12.87 billion after the closing bell. AIG shares gained 0.38 percent to $66.39 in after-hours trading.
    Flowers Foods, Inc. (NYSE: FLO) reported in-line earnings for its fourth quarter, while sales missed expectations. Flowers Foods shares fell 1.87 percent to $20.45 in the after-hours trading session.
    Before the markets open, Diebold Nixdorf Inc (NYSE: DBD) is projected to report its quarterly earnings at $0.32 per share on revenue of $1.31 billion. Diebold Nixdorf shares slipped 0.73 percent to close at $27.20 on Monday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Heading into its earnings following the close of trading yesterday, shares of American International Group (AIG) had gained 34% from its low on Jun. 28 to Feb. 14. Then the bottom fell out.

  • [By Ben Levisohn]

    American International Group (AIG) tumbled to the bottom of the S&P 500 today after its earnings fell well short of the Street consensus.

    Agence France-Presse/Getty Images

    AIG dropped 8.9% to $60.85 today, while the S&P 500 gained 0.5% to 2,349.25.

    Yes, AIG’s earnings were bad. It reported an operating loss of $2.72 a share, missing forecasts for a profit of 42 cents, according to Bloomberg. And it didn’t help that John Paulson’s Paulson & Co. cut its stake in the insurer.

    You’ll notice the forecast is different than what it was in my earlier post on AIG–and an AIG spokesperson even reached out to tell me that the consensus, at least according to FactSet, should had been for a loss of 61 cents a share. Why the confusion? RBC’s Mark Dwelle and Scott Heleniak have your answer:

    In reporting results AIG has recast all of its business segments, transferring various pieces to a Legacy unit, reallocating corporate expenses and net investment income as well as making some changes as to what is included within operating income, the most notable of which is that loss reserve discount effects in U.S. Commercial Insurance (and the Legacy unit) are now excluded from Operating Income. Accordingly, comparisons to prior reported results, and to some extent our 4Q16 estimates, require some reconciliation.

    Macquarie’sAmit Kumar considers the bull and bear cases on AIG:

    On 2/14, after market close, AIG reported a Q4 operating loss of $2.72 per share vs. our estimate of a $0.52 loss and street consensus of a $0.54 loss. Results are not directly comparable to street consensus due to lack of unanimity in terms of reserve adjustment estimates. Results included a higher than estimated $5.6 billion or $3.56/share of adverse development. The company had previously announced the possibility of a material reserve charge in the quarter. The bulls on the stock would note that this quar

  • [By Dan Caplinger]

    Wednesday was yet another record-setting day for the stock market, as the Dow climbed triple digits and the S&P 500 and Nasdaq Composite followed the venerable average to unprecedented heights. Economic data showing rising inflation made it more likely that the Federal Reserve will look to boost interest rates at its next Federal Open Market Committee meeting next month, and the ripples throughout the bond market sent many investors to consider stocks instead. Yet despite the substantial rally, some stocks missed out on the move higher, and American International Group (NYSE:AIG), Teck Resources (NYSE:TECK), and Movado Group (NYSE:MOV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Ben Levisohn]

    BMO’s Charles Sebaski explains why he upgraded American International Group (AIG) to Outperform from market Perform:

    Agence France-Presse/Getty Images

    AIG has been trading at discount to its tangible book given its mid-single digit return profile; however, we expect AIGs valuation to keep increasing with its improving return profile. We are now forecasting AIG to generate a 9.9% operating return on tangible common equity (ROtE) in 2018, which would be a 450 bp improvement from 2016. A double-digit return profile warrants the 1x multiple that we are applying to its tangible book value per share. While we expect AIGs return profile to benefit from lower taxes, we also expect the companys life and retirement business to improve from the rising interest rates as those spread businesses are more interest rate sensitive than the P&C business. That said, we expect continued improvement on both the loss and expense sides of the P&C as contributing factors to the ROtE improve.

    BMO also upgraded Arch Capital Group (ACGL), Brown & Brown (BRO), and Travelers (TRV).

    Shares of American International Group have declined 0.4% to $65.60 at 3:36 p.m. today, whileArch Capital Group has gained 2% to $87.90,Brown & Brown has advanced 0.5% to $44.65, andTravelers has risen 1.3% to $120.79.

Best Insurance Stocks To Own Right Now

Brighthouse Leaps Into the Annuity Future

Life Insurers May Get an FSOC Bill Onto Trump’s Desk

Your Social Security Number Now Looks Like a Time Bomb. It Is

Centene Corp., a Medicaid plan manager that has been doing well in the Affordable Care Act public exchange market, is expanding into New York state.

The St. Louis-based company said Tuesday it will pay $3.75 billion to acquire “substantially all of the assets” of New York State Catholic Health Plan Inc., which does business as Fidelis Care. Fidelis is a nonprofit health coverage provider based in New York.

Fidelis was providing or administering health coverage for 1.6 million people on June 30, and it generated about $4.8 billion in revenue during the first half of the year. The company competes in the Medicaid plan, Children’s Health Insurance Program and individual major medical markets in New York state. 

(Related: New York Health Insurers Ask for 16.6% Boost to ACA Exchange Rates) 

Best Insurance Stocks To Own Right Now: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Prudential (PRU) , Advanced Semiconductor Engineering (ASX) and ZTO Express (ZTO) .

    Read more of Cramer’s comments about the stocks in the Lightning Round.

  • [By WWW.MONEYSHOW.COM]

    Prudential Financial (PRU) is also a major provider of asset management and retirement services. It focuses is on fixed income, a major liability during the past eight years of ultra-low interest rates.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) has long had the Rock of Gibraltar as its corporate symbol, representing its solid financial position. With more cash and equivalents than debt on its balance sheet, and a total cash hoard of over $49 billion, Prudential still looks set up to handle some downright awful insurable losses. That’s its “Rock of Gibraltar” strength showing through.

Best Insurance Stocks To Own Right Now: American International Group Inc.(AIG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was yet another record-setting day for the stock market, as the Dow climbed triple digits and the S&P 500 and Nasdaq Composite followed the venerable average to unprecedented heights. Economic data showing rising inflation made it more likely that the Federal Reserve will look to boost interest rates at its next Federal Open Market Committee meeting next month, and the ripples throughout the bond market sent many investors to consider stocks instead. Yet despite the substantial rally, some stocks missed out on the move higher, and American International Group (NYSE:AIG), Teck Resources (NYSE:TECK), and Movado Group (NYSE:MOV) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Ben Levisohn]

    American International Group (AIG) tumbled to the bottom of the S&P 500 today after its earnings fell well short of the Street consensus.

    Agence France-Presse/Getty Images

    AIG dropped 8.9% to $60.85 today, while the S&P 500 gained 0.5% to 2,349.25.

    Yes, AIG’s earnings were bad. It reported an operating loss of $2.72 a share, missing forecasts for a profit of 42 cents, according to Bloomberg. And it didn’t help that John Paulson’s Paulson & Co. cut its stake in the insurer.

    You’ll notice the forecast is different than what it was in my earlier post on AIG–and an AIG spokesperson even reached out to tell me that the consensus, at least according to FactSet, should had been for a loss of 61 cents a share. Why the confusion? RBC’s Mark Dwelle and Scott Heleniak have your answer:

    In reporting results AIG has recast all of its business segments, transferring various pieces to a Legacy unit, reallocating corporate expenses and net investment income as well as making some changes as to what is included within operating income, the most notable of which is that loss reserve discount effects in U.S. Commercial Insurance (and the Legacy unit) are now excluded from Operating Income. Accordingly, comparisons to prior reported results, and to some extent our 4Q16 estimates, require some reconciliation.

    Macquarie’sAmit Kumar considers the bull and bear cases on AIG:

    On 2/14, after market close, AIG reported a Q4 operating loss of $2.72 per share vs. our estimate of a $0.52 loss and street consensus of a $0.54 loss. Results are not directly comparable to street consensus due to lack of unanimity in terms of reserve adjustment estimates. Results included a higher than estimated $5.6 billion or $3.56/share of adverse development. The company had previously announced the possibility of a material reserve charge in the quarter. The bulls on the stock would note that this quar

  • [By Ben Levisohn]

    Heading into its earnings following the close of trading yesterday, shares of American International Group (AIG) had gained 34% from its low on Jun. 28 to Feb. 14. Then the bottom fell out.

  • [By Ben Levisohn]

    BMO’s Charles Sebaski explains why he upgraded American International Group (AIG) to Outperform from market Perform:

    Agence France-Presse/Getty Images

    AIG has been trading at discount to its tangible book given its mid-single digit return profile; however, we expect AIGs valuation to keep increasing with its improving return profile. We are now forecasting AIG to generate a 9.9% operating return on tangible common equity (ROtE) in 2018, which would be a 450 bp improvement from 2016. A double-digit return profile warrants the 1x multiple that we are applying to its tangible book value per share. While we expect AIGs return profile to benefit from lower taxes, we also expect the companys life and retirement business to improve from the rising interest rates as those spread businesses are more interest rate sensitive than the P&C business. That said, we expect continued improvement on both the loss and expense sides of the P&C as contributing factors to the ROtE improve.

    BMO also upgraded Arch Capital Group (ACGL), Brown & Brown (BRO), and Travelers (TRV).

    Shares of American International Group have declined 0.4% to $65.60 at 3:36 p.m. today, whileArch Capital Group has gained 2% to $87.90,Brown & Brown has advanced 0.5% to $44.65, andTravelers has risen 1.3% to $120.79.

Best Insurance Stocks To Own Right Now: Aon Corporation(AON)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    We’re seeing the exact same price pattern playing out in shares of $29 billion risk and insurance consultancy firm Aon plc (AON) . Aon has been a strong performer for all of 2016, up 20% since the calendar flipped to January. But don’t worry if you’ve missed the move – an ascending triangle pattern is signaling a second leg higher here. For Aon, the breakout level to watch is resistance up at $113.

Best Insurance Stocks To Own Right Now: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Undervalued Stocks To Watch Right Now

The steel industry is garnering a lot of attention this year due to expectations of increased economic activity and the President’s announcement that new oil and gas pipeline construction will be built with U.S.-manufactured steel, observes Crista Huff, editor of Cabot Undervalued Stocks Advisor.

I’m adding Schnitzer Steel Industries (SCHN) to the Buy Low Opportunities Portfolio. Schnitzer Steel is both a recycler of scrap metals, and a manufacturer of steel products that are used in nonresidential construction.

The company also owns over 50 stores that sell used auto parts. Schnitzer is based in Oregon and exports 60% of its steel products to international destinations. The company is run by a woman who has an investment banking background. Schnitzer is considered to be well managed and benefiting from a recent focus on cost cutting.

Schnitzer’s full-year 2016 earnings per share were $0.48 (August year-end). Wall Street expects $1.21 and $1.48 EPS in fiscal 2017 and 2018, representing earnings growth of 152% and 22.3%. The corresponding P/Es are 19.6 and 16.0. The company’s long-term debt-to-capitalization ratio is 27%, down from 32% three years ago. Schnitzer last announced a quarterly dividend increase in April of 2012. The current yield is 3.1%. The number of basic shares outstanding has been relatively unchanged over the last five years. 91% of those shares are held by financial institutions, which means that professional investors think that SCHN is a good investment.

Top 10 Undervalued Stocks To Watch Right Now: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Crossamerica Partners LP (NYSE: CAPL) is projected to report its quarterly earnings at $0.05 per share on revenue of $479.03 million.

    Buckeye Partners, L.P. (NYSE: BPL) is expected to report its quarterly earnings at $1.04 per share on revenue of $1.00 billion.

Top 10 Undervalued Stocks To Watch Right Now: Westlake Chemical Corporation(WLK)

Advisors’ Opinion:

  • [By Monica Gerson] Related SAIC Q4 Earnings Conference Call: Full Transcript 7 Stocks You Should Be Watching Today Notable earnings before Monday's open (Seeking Alpha)
    Related WLK Benzinga's Weekend M&A Chatter Mid-Afternoon Market Update: Dow Falls Over 150 Points; Crude Oil Down 2.5% Westlake Chemical (WLK) CEO Albert Chao to Acquire Axiall Corporation – Earnings Call Transcript (Seeking Alpha)

    Some of the stocks that may grab investor focus today are:

Top 10 Undervalued Stocks To Watch Right Now: KongZhong Corporation(KZ)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Undervalued Stocks To Watch Right Now: CST Brands, Inc.(CST)

Advisors’ Opinion:

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion. CST Brands shares declined 1.20 percent to close at $36.21 on Thursday.

  • [By Monica Gerson]

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

    American Axle & Manufact. Holdings, Inc. (NYSE: AXL) is expected to report its quarterly earnings at $0.71 per share on revenue of $998.76 million.

Top 10 Undervalued Stocks To Watch Right Now: Oil States International Inc.(OIS)

Advisors’ Opinion:

  • [By Michael J. Carr]

    Einhorn selects investments with a traditional value approach, although he may not be as patient as a typical value investor. Einhorn took Apple (Nasdaq: AAPL) to court in an effort to force the company to return cash to shareholders, and more recently challenged Oil States International (NYSE: OIS) to unlock shareholder value.

  • [By Wayne Duggan]

    Instead, Genargo prefers oil services stocks with the most exposure to the U.S market. Loop names Halliburton Company (NYSE: HAL) as its top large-cap stock pick and Oil States International, Inc. (NYSE: OIS), Newpark Resources Inc (NYSE: NR) and Superior Energy Services, Inc. (NYSE: SPN) as its top small- and mid-cap stocks.

Top 10 Undervalued Stocks To Watch Right Now: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

Top 10 Undervalued Stocks To Watch Right Now: CNH Industrial N.V.(CNHI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    I wrote bullishly about Deere (DE) back in December, and since then the stock has done…not much, gaining 4.8% to the S&P 500′s 4.1% rise. So I’ve tried to stay on top of the stock, both the bullish calls and the bearish ones–and today, I have another bear to add to the list. That would be JPMorgan’s Ann Duignan, who reiterated her Underweight rating on Deere today, as well as CNH Industrial (CNHI) and Agco (AGCO). She explains why:

Top 10 Undervalued Stocks To Watch Right Now: TravelCenters of America LLC(TA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares dipped by 0.70 percent. Meanwhile, top losers in the sector included TravelCenters of America LLC (NYSE: TA), down 18 percent, and Alon USA Energy, Inc. (NYSE: ALJ), down 8 percent.

Top 10 Undervalued Stocks To Watch Right Now: Pentair plc.(PNR)

Advisors’ Opinion:

  • [By William Patalon III]

    Water-equipment company – and Private Briefing favorite – Pentair PLC (NYSE: PNR) left investors with mixed feelings after reported its earnings on Tuesday.

  • [By Ben Levisohn]

    RBC’s Deane Dray and team worry that valuations of industrial stocks like General Electric (GE), Danaher (DHR), Honeywell International (HON), Ingersoll-Rand (IR) and Pentair (PNR) have gotten ahead of themselves and recommend a “barbell strategy” when playing the sector. They explain:

  • [By Lee Jackson]

    Pentair PLC(NYSE: PNR) had a major holder and director of the company buying more shares last week. Trian Fund purchased 863,000 shares of this diversified industrial manufacturing company at prices that ranged from $65.13 to $65.41 apiece. The total for the trade was posted at a huge $56 million. The stock closed Friday at $67.11, so the purchase appears to be well timed. The52-week trading range is $53.80 to $69.03, and the Wall Street consensus price objective is $67.50.

  • [By Ben Levisohn]

    While the direct revenue exposure to the UK is relatively small across our coverage (aside fromTyco and Idex), the potential impact from Brexit is much more widespread across the continent and the world. The impact should be most negative for our companies with larger industrial exposure to Europe, just as we have begun to hear incrementally positive commentary regarding Europe.Idex andTyco have some of the highest direct exposures to UK and Europe but Tyco’s business should be relatively more stable and in any case theJohnson Controls (JCI) synergies loom large. Eaton (ETN) and Emerson Electric, though with slightly smaller exposure, are more involved with industrial spending.Danaher andHoneywell have high revenue exposure, but we believe that their more benign end market exposure should mitigate some of the negative consequences they face. We rate Allegion (ALLE), Danaher, Dover (DOV), Fortive (FTV), Honeywell, Ingersoll-Rand (IR), Pentair (PNR) andTyco Outperform; Emerson Electric, Eaton, General Electric (GE),Idex and 3M (MMM) Market-Perform; Rockwell Automation (ROK) Underperform.

Top 10 Undervalued Stocks To Watch Right Now: Amphenol Corporation(APH)

Advisors’ Opinion:

  • [By Darren Williams] Although the entire cannabis space has quietly taken a hit of their own medicine in recent weeks and gone to sleep, don’t think for one second the entire space isn’t going to light up again soon. That’s just what they do, right? However, knowing who the pretenders are and knowing who the contenders are is really the challenge when it’s comes right down to it.
    First, anyone who claims to be a grower or a seller of cannabis can’t for one second ever make it as a public company right now, or can even legally consider being a public company for that matter, so you can scratch any of those right off your list. At least here in the U.S. anyway, because Canada is already well ahead of the curve having legalized it for medicinal purposes already.
    More importantly, full legalization of marijuana in Canada appears to be on track for July 2018, which will make Canada just the second nation in the world after Uruguay to completely legalize the cultivation, sale and possession of the drug for medical and recreational purposes.
    Regardless, the best time to buy any stocks in a hot growth sector is when either everyone has forgotten about them, or when the overall market landscape has turned bearish, which has yet to happen. However, the former seems to be the case for the cannabis space, despite some very favorable state legislation last Fall.
    For now, as long as you have a license issued by Health Canada, you’re good to go, so there are some stocks trading in Canada already who are well on their way to making some green for investors. Canopy Growth Corporation (TSE: WEED), formerly Tweed Marijuana Inc., is a medical marijuana company based in Smiths Falls, Ontario. Aurora Cannabis Inc. (CVE: ACB), which is engaged in the production and sale of medical cannabis. There’s also Aphria Pharmaceutical Company (TSE: APH), which also is engaged in producing and selling medical marijuana through retail sales and wholesale channels.
    There are many more, but those are just a
  • [By Lee Jackson]

    This is the top pick in the sector and has remained a favorite at RBC for some time.Amphenol Corp. (NYSE: APH) is one of the worlds largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors, interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable.

online day trading

Done with the job? Ready to do your own thing?

Those who are on track to be “financially independent and retiring early” — or “FIRE” — are.

You’d need to be fired up to sock away enough money to quit your job and retire in just five years. But it’s not impossible.

Some people, like Claudia and Garrett Pennington take extreme measures like saving 67% of their income and making big lifestyle choices. They almost never eat out, have no cable subscriptions and even dramatically downsized their home.

While that’s probably too much sacrifice for most people, see if you’re on track to make it to financial freedom in 10, 15 or 20 years.

This couple is on track to retire — before they turn 40

Being financially independent means that income from your investments alone is enough to cover all your expenses.

So how do you get there?

The sunshine that makes most retirement funds grow is compound interest. And it takes time to grow. But if you plan to retire early, you might not have as much time as someone targeting a traditional retirement.

online day trading: Arch Coal, Inc. (ARCH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The VanEck Vectors Coal ETF has gained 1.1% to $12.28 at 2:01 p.m. today, while Arch Coal (ARCH), which resumed listed trading yesterday after emerging from bankruptcy, has fallen 3% to $62.98.

online day trading: Rockwell Collins, Inc.(COL)

Advisors’ Opinion:

  • [By Lisa Levin]

    United Technologies Corporation (NYSE: UTX) will acquire Rockwell Collins, Inc. (NYSE: COL) in a deal worth $30 billion , forging an aerospace behemoth producing virtually all types of avionics systems for commercial and defense aircraft.

  • [By Lu Wang]

    Rockwell Collins (COL) sank 4.9 percent to $70.61. The maker of airplane cockpit instruments forecast revenue in fiscal 2014 will be no more than $4.60 billion. That missed the average analyst estimate of $4.93 billion in a Bloomberg survey.

  • [By Lisa Levin] Related TRST Earnings Scheduled For October 21, 2016 Major Accounting Changes Are Coming To The Financial Industry
    Related MORN One Of The World's Most Powerful Women, Fidelity Personal Investing President Kathleen Murphy, To Tell Her Story At The Benzinga Global Fintech Awards The 2017 Benzinga Global Fintech Awards Will Include An 'Unprecedented Group' Of Judges Morningstar Packs Conference Lineup For Financial Advisors (Investor’s Business Daily) Companies Reporting Before The Bell
    Rockwell Collins, Inc. (NYSE: COL) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.33 billion.
    General Electric Company (NYSE: GE) is expected to report quarterly earnings at $0.17 per share on revenue of $26.46 billion.
    Honeywell International Inc. (NYSE: HON) is estimated to report quarterly earnings at $1.60 per share on revenue of $9.32 billion.
    Interpublic Group of Companies Inc (NYSE: IPG) is expected to report quarterly earnings at $0.03 per share on revenue of $1.76 billion.
    Schlumberger Limited. (NYSE: SLB) is estimated to report quarterly earnings at $0.26 per share on revenue of $7.02 billion.
    SunTrust Banks, Inc. (NYSE: STI) is expected to report quarterly earnings at $0.83 per share on revenue of $2.21 billion.
    ManpowerGroup Inc. (NYSE: MAN) is projected to report quarterly earnings at $1.11 per share on revenue of $4.68 billion.
    Kansas City Southern (NYSE: KSU) is estimated to report quarterly earnings at $1.15 per share on revenue of $593.82 million.
    Stanley Black & Decker, Inc. (NYSE: SWK) is projected to report quarterly earnings at $1.19 per share on revenue of $2.74 billion.
    WABCO Holdings Inc. (NYSE: WBC) is estimated to report quarterly earnings at $1.44 per share on revenue of $721.89 million.
  • [By Ben Levisohn]

    Rockwell Collins (COL) has fallen 2.6% to $68.21 after it was downgraded to Neutral from Outperform at Credit Suisse.

    General Electric (GE) has gained 1% to $24.25 after signing a bunch of deals and getting a positive mention from my colleague Jack Hough in this weekend’s Barron’s.

  • [By Jayson Derrick]

    Honorable Mention: Rockwell Collins, Inc. (NYSE: COL) with a $122 price target.

    Technology, Media And Telecom

    Within the crowded technology, media and telecommunication group, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) is a top pick given its prospects for continued growth in mobile search and YouTube. Beyond these two segments, the analysts also see continued momentum in Alphabet’s core Google operations.

  • [By Stephen Mack]

    The biggest aerospace deal in history was announced Monday, as United Technologies Corp. (NYSE: UTX) agreed to acquire aviation parts manufacturer Rockwell Collins Inc. (NYSE: COL) for $23 billion.

online day trading: Applied Materials, Inc.(AMAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Wal-Mart Stores Inc (NYSE: WMT) to report quarterly earnings at $0.97 per share on revenue of $120.89 billion before the opening bell. Wal-Mart shares slipped 0.26 percent to $89.60 in after-hours trading.
    Analysts expect Applied Materials, Inc. (NASDAQ: AMAT) to post quarterly earnings at $0.91 per share on revenue of $3.94 billion after the closing bell. Applied Materials shares rose 0.50 percent to $56.05 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday. Cisco shares gained 5.83 percent to $36.10 in the after-hours trading session.
    After the closing bell, Williams-Sonoma, Inc. (NYSE: WSM) is expected to post quarterly earnings at $0.84 per share on revenue of $1.29 billion. Williams-Sonoma shares gained 1.61 percent to $51.60 in after-hours trading.
    Analysts are expecting Viacom, Inc. (NASDAQ: VIAB) to have earned $0.86 per share on revenue of $3.23 billion in the latest quarter. Viacom will release earnings before the markets open. Viacom shares gained 0.29 percent to close at $24.61 on Wednesday.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance. NetApp shares climbed 11.41 percent to $51.05 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By William Patalon III]

    Shares of chip-equipment leader Applied Materials Inc. (Nasdaq: AMAT) have zoomed 80% since we brought them to you in May 2014.

    And they’ve jumped 8% since we re-recommended the stock back on Jan. 31.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about a bullish options activity in Applied Materials, Inc. (NASDAQ: AMAT). He noticed that somebody sold 12,000 contracts of the September 42 puts in the first half of the trading session on Tuesday. Najarian explained that the trader believes that the pull back might be over and the stock is close to the bottom.

  • [By Chris Lange]

    Applied Materials Inc. (NASDAQ: AMAT) short interest rose slightly to 15.21 million shares. The previous reading was 15.17 million. Shares closed Friday at $31.88, in a 52-week range of $15.44 to $31.97.

online day trading: RepliCel Life Sciences Inc. (REPCF)

Advisors’ Opinion:

  • [By Sara Cornell]

    RepliCel Life Sciences Inc. (OTCBB: REPCF) (TSX: RP.V) – could be changing the way we treat baldness and hair loss in the future.

    A clinical-stage regenerative medicine company, RepliCel is developing a unique biologic product that harnesses a patient’s own cells to treat pattern baldness and thinning hair, as well as products for aging and sun-damaged skin, and chronic tendon degeneration. The company recently announced the successful completion of its first-in-human clinical study of autologous cell therapy for the treatment of Androgenetic Alopecia, commonly known as pattern baldness.

Top Clean Energy Stocks To Buy Right Now

Federal investigators have halted an alleged student loan debt relief scam that bilked more than $11 million from consumers nationwide.

Strategic Student Solutions and several related companies falsely promised to reduce or eliminate student loan debt and also offered the borrowers non-existent credit repair services, in exchange for upfront fees and monthly payments, the Federal Trade Commission charged incourt papersmade public Thursday.

Although borrowers allegedly got no relief from their debts, Dave Green, owner of the companies, used corporate funds to pay for jewelry, casino tabs, mortgage payments, luxury vehicles and construction of a pool, the FTC charged.

.oembed-asset-link { border-bottom: 1px solid #e1e1e1; } .oembed-link-anchor { display: block; clear: both; } p.oembed-link-desc { font-size: 100%; color: #666; font-weight: normal; margin: 0 14px 14px 14px; font-family: ‘Futura Today Light’; text-align: left; line-height: 120%; }

FTC Complaint v Strategic Student Solutions

Top Clean Energy Stocks To Buy Right Now: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top Clean Energy Stocks To Buy Right Now: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Charles Carlson, CEO and Portfolio Manager, Horizon Investment Services]

    For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).

Top Clean Energy Stocks To Buy Right Now: Brookfield Renewable Powerr Fund(BEP)

Advisors’ Opinion:

  • [By Federico Zaldua]

    I expect the Brookfield Group of Companies, which is composed of no fewer than 15 publicly traded entities, to be very active acquisitive in the near-term future. Here I focus my attention on three members of the Brookfield Group that are going to be the most active with M&A. While Brookfield Asset Management (BAM) will concentrate its M&A efforts into all geographies and all asset classes, Brookfield Renewable Energy Partners (BEP) and Brookfield Infrastructure Partners (BIP) will concentrate on their respective industries. Let’s see whether you should go long on any of this separate -although related – entities.

    Good Operational Performance

    Brookfield Asset Management, held by Lou Simpson and Ron Baron, counts with a liquidity position of more than $5 billion at the parent and principal subsidiaries along with nearly $10 billion drawable private fund commitments. More importantly, the company has expressed its interest into using this liquidity to make acquisitions. Management clearly stated in its letter to shareholders:

Top Clean Energy Stocks To Buy Right Now: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The six companies that met the criterion are:

    Oshkosh Corp (NYSE: OSK). Phillips 66 (NYSE: PSX). SpartanNash Co (NASDAQ: SPTN). Suncor Energy Inc. (USA) (NYSE: SU). Washington Federal Inc. (NASDAQ: WAFD). Barnes & Noble, Inc. (NYSE: BKS).
    Oshkosh

    Oshkosh is a manufacturer of specialty vehicles and vehicle bodies and is based in Wisconsin. The company operates under four business segments, namely access equipment, defense, fire and emergency, and commercial.

  • [By Paul Ausick]

    Phillips 66 (NYSE: PSX) said on Saturday that its operated Pasadena refined products terminal resumed truck loading and diesel loading is set to begin Sunday. Activities at the Mont Belvieu fractionator has been suspended due to a lack of available storage at the Mont Belvieu hub. The company is checking its Sweeny refinery (247,000 barrels a day) for damage and making repairs before resuming operations.

  • [By WWW.THESTREET.COM]

    “As a technician, I see largely rangebound motion with big bounces being retraced and fades being bought at deep support,” she added. “As the markets opened, holding over $48.12 will likely spell a bullish run as several refineries are closed in the region, such as Phillips66 (PSX) , Shell Petrobras and Exxon (XOM) . The support tests that hold $47.3 will be buy zones more than likely. Overall, the current remains the same – a largely landlocked region with only temporary moves up or down until the rebalancing looks better.”

  • [By WWW.KIPLINGER.COM]

    Refiners and downstream energy stocks have really gone to town as oil prices have listed lower in a relatively tight range. Phillips 66 (PSX) is among those winners.

  • [By Virendra Singh Chauhan]

    Another piece of the Berkshire puzzle which could ride a tailwind is the investment in oil major Phillips 66 (NYSE:PSX). With OPEC recently making a move to support oil prices with supply cuts, a rising oil price will benefit the oil major which made up just over 5% of Berkshire’s stock holdings at the end of the September quarter. PSX stock price is up 11% over the last one month and could be headed further higher if the demand/supplydynamics of the oil market are brought under control. (See also: Berkshire Stock: Should Investors Worry About Warren Buffett’s Latest Investments?)

  • [By Matthew DiLallo]

    After facing several challenges in 2016 that pushed down results, Phillips 66 (NYSE:PSX) bounced back big-time in the first quarter. The company trounced the consensus estimate by a whopping $0.51 per share, which was roughly 10 times higher than the $0.05 per share analysts expected.

Top Clean Energy Stocks To Buy Right Now: China Mobile (Hong Kong) Ltd.(CHL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell 0.12 percent. Meanwhile, top losers in the sector included China Mobile Ltd. (ADR) (NYSE: CHL), down 3 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 1.5 percent.

  • [By David Goodboy]

    Rumors are that Apple will use this opportunity to announce the long-awaited deal with China Mobile (NYSE: CHL), which is the world's largest cellphone carrier with more than 700 million active users. Clearly, there are impediments in the way, but the potential for a lower-priced iPhone for this market means strong possibilities remain. This deal would be a major upside catalyst for Apple shares.

  • [By Motif Investing]

    The most heavily weighted names in the motif are China Mobile Ltd. (ADR) (NYSE: CHL), Aibaba Group Holding Ltd (NYSE: BABA), Baidu Inc (NASDAQ: BIDU), India's HDFC Bank (NYSE: HDB) and Russia's Mobile TeleSystems PJSC (NYSE: MBT).

David Einhorn Buys Brighthouse Financial Inc, Tempur Sealy International Inc, Adient PLC, Sells Gene

Investment company David Einhorn buys Brighthouse Financial Inc, Tempur Sealy International Inc, Adient PLC, Micron Technology Inc, Hewlett Packard Enterprise Co, Exela Technologies Inc, Venator Materials PLC, DSW Inc, Children’s Place Inc, Tech Data Corp, sells General Motors Co, Apple Inc, Calpine Corp, Calpine Corp, The Chemours Co during the 3-months ended 2017-09-30, according to the most recent filings of the investment company, Greenlight Capital. As of 2017-09-30, Greenlight Capital owns 39 stocks with a total value of $6.3 billion. These are the details of the buys and sells.

New Purchases: BHF, XELA, VNTR, PLCE, TECD, DLTR, GPS, KR, Added Positions: TPX, ADNT, MU, HPE, PRGO, DSW, Reduced Positions: GM, AAPL, CC, UHAL, DDS, RAD, QHC, FRED, Sold Out: CPN, CPN, PVH, AA, NYRT, MCFYY,

For the details of David Einhorn’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=David+Einhorn

These are the top 5 holdings of David EinhornGeneral Motors Co (GM) – 34,561,500 shares, 22.24% of the total portfolio. Shares reduced by 36.88%AerCap Holdings NV (AER) – 12,355,508 shares, 10.06% of the total portfolio. Shares reduced by 0.84%Brighthouse Financial Inc (BHF) – 6,792,028 shares, 6.58% of the total portfolio. New PositionConsol Energy Inc (CNX) – 22,661,081 shares, 6.12% of the total portfolio. Shares reduced by 0.01%Apple Inc (AAPL) – 2,192,900 shares, 5.39% of the total portfolio. Shares reduced by 44.18%New Purchase: Brighthouse Financial Inc (BHF)

David Einhorn initiated holdings in Brighthouse Financial Inc. The purchase prices were between $53 and $70, with an estimated average price of $59.98. The stock is now traded at around $56.44. The impact to the portfolio due to this purchase was 6.58%. The holdings were 6,792,028 shares as of 2017-09-30.

New Purchase: Exela Technologies Inc (XELA)

David Einhorn initiated holdings in Exela Technologies Inc. The purchase prices were between $4.81 and $9.99, with an estimated average price of $6.53. The stock is now traded at around $5.05. The impact to the portfolio due to this purchase was 0.65%. The holdings were 8,384,629 shares as of 2017-09-30.

New Purchase: Venator Materials PLC (VNTR)

David Einhorn initiated holdings in Venator Materials PLC. The purchase prices were between $18.36 and $22.9, with an estimated average price of $20.74. The stock is now traded at around $23.37. The impact to the portfolio due to this purchase was 0.61%. The holdings were 1,700,000 shares as of 2017-09-30.

New Purchase: Children’s Place Inc (PLCE)

David Einhorn initiated holdings in Children’s Place Inc. The purchase prices were between $99.65 and $118.05, with an estimated average price of $107.33. The stock is now traded at around $128.00. The impact to the portfolio due to this purchase was 0.13%. The holdings were 66,400 shares as of 2017-09-30.

New Purchase: Tech Data Corp (TECD)

David Einhorn initiated holdings in Tech Data Corp. The purchase prices were between $82.61 and $110.29, with an estimated average price of $98.9. The stock is now traded at around $91.42. The impact to the portfolio due to this purchase was 0.13%. The holdings were 90,000 shares as of 2017-09-30.

New Purchase: Dollar Tree Inc (DLTR)

David Einhorn initiated holdings in Dollar Tree Inc. The purchase prices were between $66.39 and $85.68, with an estimated average price of $76.03. The stock is now traded at around $97.47. The impact to the portfolio due to this purchase was 0.12%. The holdings were 87,900 shares as of 2017-09-30.

Added: Tempur Sealy International Inc (TPX)

David Einhorn added to the holdings in Tempur Sealy International Inc by 900.00%. The purchase prices were between $50.11 and $63.76, with an estimated average price of $58.91. The stock is now traded at around $56.48. The impact to the portfolio due to this purchase was 3.7%. The holdings were 4,000,000 shares as of 2017-09-30.

Added: Adient PLC (ADNT)

David Einhorn added to the holdings in Adient PLC by 294.16%. The purchase prices were between $63.99 and $85.71, with an estimated average price of $70.62. The stock is now traded at around $78.10. The impact to the portfolio due to this purchase was 1.73%. The holdings were 1,731,000 shares as of 2017-09-30.

Added: Micron Technology Inc (MU)

David Einhorn added to the holdings in Micron Technology Inc by 89.51%. The purchase prices were between $27.49 and $37.96, with an estimated average price of $31.46. The stock is now traded at around $48.54. The impact to the portfolio due to this purchase was 1.49%. The holdings were 5,021,900 shares as of 2017-09-30.

Added: Hewlett Packard Enterprise Co (HPE)

David Einhorn added to the holdings in Hewlett Packard Enterprise Co by 75.39%. The purchase prices were between $12.68 and $14.89, with an estimated average price of $13.56. The stock is now traded at around $14.27. The impact to the portfolio due to this purchase was 0.79%. The holdings were 7,805,000 shares as of 2017-09-30.

Added: DSW Inc (DSW)

David Einhorn added to the holdings in DSW Inc by 35.14%. The purchase prices were between $15.69 and $21.5, with an estimated average price of $18.34. The stock is now traded at around $19.71. The impact to the portfolio due to this purchase was 0.27%. The holdings were 3,049,000 shares as of 2017-09-30.

Sold Out: Calpine Corp (CPN)

David Einhorn sold out the holdings in Calpine Corp. The sale prices were between $13.11 and $14.92, with an estimated average price of $14.27.

Sold Out: Calpine Corp (CPN)

David Einhorn sold out the holdings in Calpine Corp. The sale prices were between $13.11 and $14.92, with an estimated average price of $14.27.

Sold Out: PVH Corp (PVH)

David Einhorn sold out the holdings in PVH Corp. The sale prices were between $110.88 and $129.6, with an estimated average price of $121.67.

Sold Out: Alcoa Corp (AA)

David Einhorn sold out the holdings in Alcoa Corp. The sale prices were between $33.77 and $47.5, with an estimated average price of $39.79.

Sold Out: New York REIT Inc (NYRT)

David Einhorn sold out the holdings in New York REIT Inc. The sale prices were between $7.64 and $8.69, with an estimated average price of $8.31.

Sold Out: Micro Focus International PLC (MCFYY)

David Einhorn sold out the holdings in Micro Focus International PLC. The sale prices were between $32.93 and $32.93, with an estimated average price of $32.93.

Reduced: General Motors Co (GM)

David Einhorn reduced to the holdings in General Motors Co by 36.88%. The sale prices were between $34.76 and $40.58, with an estimated average price of $36.53. The stock is now traded at around $44.92. The impact to the portfolio due to this sale was -11.38%. David Einhorn still held 34,561,500 shares as of 2017-09-30.

Reduced: Apple Inc (AAPL)

David Einhorn reduced to the holdings in Apple Inc by 44.18%. The sale prices were between $142.73 and $164.05, with an estimated average price of $155.13. The stock is now traded at around $172.54. The impact to the portfolio due to this sale was -4.03%. David Einhorn still held 2,192,900 shares as of 2017-09-30.

Reduced: The Chemours Co (CC)

David Einhorn reduced to the holdings in The Chemours Co by 58.79%. The sale prices were between $38.1 and $51.95, with an estimated average price of $47.08. The stock is now traded at around $52.17. The impact to the portfolio due to this sale was -1.29%. David Einhorn still held 1,485,000 shares as of 2017-09-30.

Reduced: Amerco Inc (UHAL)

David Einhorn reduced to the holdings in Amerco Inc by 77.27%. The sale prices were between $352.21 and $396.3, with an estimated average price of $373.25. The stock is now traded at around $353.44. The impact to the portfolio due to this sale was -1%. David Einhorn still held 50,000 shares as of 2017-09-30.

Reduced: Dillard’s Inc (DDS)

David Einhorn reduced to the holdings in Dillard’s Inc by 40.37%. The sale prices were between $54.02 and $78.87, with an estimated average price of $61.54. The stock is now traded at around $53.19. The impact to the portfolio due to this sale was -0.94%. David Einhorn still held 1,500,000 shares as of 2017-09-30.

Reduced: Quorum Health Corp (QHC)

David Einhorn reduced to the holdings in Quorum Health Corp by 81.31%. The sale prices were between $2.94 and $4.91, with an estimated average price of $4.05. The stock is now traded at around $4.57. The impact to the portfolio due to this sale was -0.06%. David Einhorn still held 205,000 shares as of 2017-09-30.

Here is the complete portfolio of David Einhorn. Also check out:

1. David Einhorn’s Undervalued Stocks
2. David Einhorn’s Top Growth Companies, and
3. David Einhorn’s High Yield stocks
4. Stocks that David Einhorn keeps buying

Russia may build its new jetliners in the Middle East

Russia isn’t just trying to sell its new airliner abroad. It might build it there, too.

State-owned military-industrial giant Rostec, which is responsible for exporting Russian technology, said Sunday that it has started talks to jointly produce a commercial plane overseas — potentially in the United Arab Emirates.

The short statement, which coincided with the start of the Dubai air show, didn’t provide much detail. But Russia is trying to increase exports of its new large single-aisle airliner, the Irkut MC-21, which competes directly with Boeing (BA) and Airbus (EADSF) planes.

One strategy that plane makers employ to boost sales is using overseas manufacturing to gain market access with local airlines. Europe’s Airbus, for example, opened final assembly lines for its A320 jets in China and the U.S. to produce planes specifically to attract airlines in both countries.

The UAE is home to two of the world’s biggest carriers, Emirates and Etihad, as well as several smaller ones.

The MC-21, the first Russian-made airliner of its size since the fall of the Soviet Union, is backed at the highest levels of the Russian government. President Vladimir Putin has pushed for Rostec and state-owned United Aircraft Corporation (UAC) to increase sales of the plane to both Russian and foreign airlines.

Rostec said it held talks about the potential joint production of the plane with Sheikh Mohammed bin Zayed al-Nahyan, the powerful crown prince of Abu Dhabi.

united aircraft corporation irkut mc 21 The MC-21-300 has been flying since May 2017.

The UAE has been eager to expand its aerospace industry into manufacturing. Companies based in the country already produce some parts for Boeing and Airbus jets.

A Rostec spokesperson said it was too early to say what joint production would mean in practice. It could entail anything from assembly of completed MC-21 jetliners in the UAE to manufacturing components for jets that will be produced in Russia.

“Specific parameters will be determined during [the] negotiation process,” the spokesperson said.

Russia is increasingly open to cross-border partnerships to expand its aerospace industry. UAC has teamed up with China’s Comac to design and produce a new long range twin-aisle airliner, but that plane’s not expected to be ready for at least another eight to 10 years.

The aircraft Rostec and UAC may build in the UAE would be based on the largest version, the MC-21-400, that seats up to 250 passengers and competes directly with the biggest single-aisle jets from Boeing and Airbus.

A smaller version, the MC-21-300, has been carrying out early flight trials since May.

Many MC-21 parts comes from Western suppliers: Its engines, for example, are made by Connecticut-based Pratt & Whitney. But final assembly of the aircraft is completed in the Siberian city of Irkutsk.

Russian aircraft company Sukhoi, which is also a unit of UAC, partnered for a time with Italy’s biggest aerospace company to install interiors of its new Superjet regional airliner in Venice for European customers.